New opioid analgesics: An update

International Anesthesiology Clinics

Volumn 35, Issue 2, 1997, Pages 49-65

  Minto, Charles F ^a   Power, Ian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

REMIFENTANIL; TRAMADOL; TREFENTANIL;

ANALGESIA; ANALGESIC ACTIVITY; CORONARY ARTERY BYPASS SURGERY; DOSE RESPONSE; DROWSINESS; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG METABOLISM; DRUG POTENCY; HUMAN; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW;

EID: 0030851441     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199703520-00005     Document Type: Review

References (96)

1. Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275-285
2. Hennies HH, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittel-Forschung 1988;38: 877-880
3. Vickers MD, O'Flaherty D, Szekely SM, et al. Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 1992;47:291-296
4. Collart L, Luthy C, Dayer P. Partial inhibition of tramadol antinociceptive effect by naloxone in man. Br J Clin Pharmacol 1993;35:73P
5. Osipova NA, Novikov GA, Beresnev VA, Loseva NA. Analgesic effect of tramadol in cancer patients with chronic pain: a comparison with prolonged-action morphine sulfate. Curr Ther Res Clin Exp 1991;50:812-821
6. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Dependence 1991;27:7-17
7. Houmes RJ, Voets MA, Verkaaik A, et al. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg 1992;74:510-514
8. Raffa RB, Friderichs E, Reimann W, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993;267: 331-340
9. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992;105: 147-151
10. Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and doparnine in vitro. Br J Pharmacol 1993;108: 806-811
11. Sevcik J, Nieber K, Driessen B, Illes P. Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones. Br J Pharmacol 1993;110:169-176
12. Calvey TN. Chirality in anaesthesia (editorial). Anaesthesia 1992;47:93-94
13. James MF, Heijke SA, Gordon PC. Intravenous tramadol versus epidural morphine for postthoracotomy pain relief: a placebo-controlled double-blind trial. Anesth Analg 1996; 83:87-91
14. Rodriguez MJ, De la Torre MR, Perez-Iraola P, et al. Comparative study of tramadol versus NSAIDs as intravenous continuous infusion for managing postoperative pain. Curr Ther Res Clin Exp 1993;54:375-383
15. Lehmann KA, Horrichs G, Hoeckle W. The significance of tramadol as an intraoperative analgesic. A randomized double-blind study in comparison with placebo [in German]. Der Anaesthesist 1985;34:11-19
16. Coetzee JF, Maritz JS, du Toit JC. Effect of tramadol on depth of anaesthesia. Br J Anaesth 1996;76:415-418
17. Lemmens HJ, Egan TD, Fiset P, Stanski DR. Pharmacokinetic/dynamic assessment in drug development: application to the investigational opioid mirfentanil. Anesth Analg 1995;80:1206-1211
18. 2 (Abstract). Anesth Analg 1992;74: S112
19. Hertz CM, Shlugman D, Dufore S, Glass PSA. Analgesic and respiratory depressant potency of mirfentanil and fentanyl (Abstract). Anesthesiology 1995;83:A387
20. Rosow CE. Newer opioid agonists. Bailliere's Clin Anaesthesiol 1995;9:67-82
21. Lemmens HJ, Dyck JB, Shafer SL, Stanski DR. Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil. Clin Pharmacol Ther 1994;56:261-271
22. 21a. Minto CF, Schnider TW, Gambus PL, et al. Trefentanil shows clinical benefit over alfentanil using respiratory pharmacodynamic measures (abstract). Anesthesiology 1996; 85:A338
23. Rosow C. Remifentanil: a unique opioid analgesic (editorial). Anesthesiology 1993;79: 875-876
24. Thompson JP, Rowbotham DJ. Remifentanil - an opioid for the 21st century (editorial). Br J Anaesth 1996;76:341-343
25. Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting, mu-opioid (review). Anesth Analg 1996;83:646-651
26. Glass PS. Remifentanil: a new opioid (review). J Clin Anesth 1995;7:558-563
27. Schraag S, Georgieff M. Intravenous anesthesia - current aspects (review) [in German]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 1995;30:469-478
28. Lemmens HJ. Pharmacokinetic-pharmacodynamic relationships for opioids in balanced anaesthesia (review). Clin Pharmacokinet 1995;29:231-242
29. Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal (review). Clin Pharmacokinet 1995;29:80-94
30. Glass PS. Pharmacology of remifentanil. Eur J Anaesthesiol 1995;10(Suppl):73-74
31. Bovill JG. New drugs. Curr Opinion Anesthesiol 1996;9:318-322
32. Lemmens HJM. Opioids in intravenous anaesthesia. Anaesthetic Pharmacol Rev 1995; 3:67-73
33. Selinger K, Nation RL, Smith GA. Enzymatic and chemical hydrolysis of remifentanil (Abstract). Anesthesiology 1995;83:A385
34. Stiller RL, Davis PJ, McGowan Jr, et al. In vitro metabolism of remifentanil: the effects of pseudocholinesterase deficiency (Abstract). Anesthesiology 1995;83:A381
35. Duthie DJR, Muir KT, Baddoo HHK, et al. Remifentanil is not metabolised by the lung (Abstract). Anesthesiology 1995;83:A324
36. Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996;84:821-833
37. Minto CF, Schnider TW, Egan TD, et al. The influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997;86:10-23
38. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995;83:968-975
39. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991;74:53-63
40. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-341
41. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993; 77:1031-1040
42. Cunningham FE, Hoke JF, Muir KT, et al. Pharmacokinetic/pharmacodynamic evaluation of remifentanil, GI90291, and alfentanil (Abstract). Anesthesiology 1995;83:A376
43. Guy J, Warner DS, Kirchner J, et al. ICP effects and emergence/recovery profile of neurosurgical patients following remifentanil/N20 anesthesia (Abstract). Anesth Analg 1996;82:S151
44. Davies PJ, Ross A, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age (Abstract). Anesth Analg 1995;80:S93
45. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903
46. Minto CF, Schnider TW, Shafer SL. The pharmacokinetics and pharmacodynamics of remifentanil II. Model application. Anesthesiology 1997;86:24-33
47. Egan TD, Gupta SK, Sperry RJ, et al. The pharmacokinetics of remifentanil in obese versus lean elective surgery patients (Abstract). Anesth Analg 1996;82:S100
48. Egan TD, Billard V, Barr J, et al. Gender has no effect on the pharmacokinetics or pharmacodynamics of remifentanil (Abstract). Anesthesiology 1995;83:A325
49. Hoke JF, Muir KT, Glass PSA, et al. Pharmacokinetics of remifentanil and its metabolite (GI90291) in subjects with renal disease (Abstract). Clin Pharmacol Ther 1995;57:PI-55
50. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996;84: 812-820
51. Navapurkar VU, Archer S, Frazer NM, et al. Pharmacokinetics of remifentanil during hepatic transplantation (Abstract). Anesthesiology 1995;83:A382
52. Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. J Pharmacol Exp Ther 1995;274:34-39
53. Sebel PS, Hoke JF, Westmorland C, et al. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 1995;80:990-993
54. Gupta SK, Warner DS, Hindman B, et al. Comparative concentration-response (ICP, CPP, MAP) relationships of remifentanil and alfentanil in neurosurgical patients (Abstract). Anesth Analg 1996;82:S149
55. Michelsen LG, Salmenpera M, Hug CC Jr, et al. Anesthetic potency of remifentanil in dogs. Anesthesiology 1996;84:865-872
56. Hug CCJ. Does opioid "anesthesia" exist? (comment) (see comments). Anesthesiology 1990;73:1-4
57. Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995;81:619-623
58. Hogue C, Camporesi E, Duncalf D, et al. Total intravenous anesthesia with remifentanil and propofol in patients undergoing elective inpatient surgery (Abstract). Anesthesiology 1995;83:A386
59. Hogue CW Jr, Bowdle TA, O'Leary C, et al. A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 1996;83:279-285
60. Kovac A, Azad S, Batenhorst R, et al. Remifentanil versus alfentanil balanced anesthesia for total abdominal hysterectomy (Abstract). Anesthesiology 1995;83:A383
61. Witkowski T, Azad SS, Lessin J, et al. Recovery following remifentanil for prolonged operations: a comparison with alfentanil (Abstract). Anesthesiology 1995;83:A378
62. Drover DR, Lemmens HJM. The pharmacodynamics of remifentanil as a supplement to nitrous oxide anesthesia during abdominal surgery (Abstract). Anesthesiology 1996; 85:A311
63. Peacock J, Reilly C, Luntley J, et al. Remifentanil in combination with propofol for spontaneous ventilation anaesthesia (Abstract). Anesthesiology 1995;83:A35
64. Munday IT, Ward PM, Sorooshian S, et al. Interaction between remifentanil and isoflurane in spontaneously breathing patients during ambulatory surgery (Abstract). Anesthesiology 1995;83:A23
65. Royston D, Kirkham A, Adt M, et al. Remifentanil based total intravenous anaesthesia (TIVA) in primary CABG surgery patients: use as a sole induction agent and hemodynamic responses throughout surgery (Abstract). Anesthesiology 1996;85:A83
66. Porembka DT, Michelsen LG, Howie MB, et al. Hemodynamic responses during CABG surgery with remifentanil anesthesia (Abstract). Anesth Analg 1996;82:S365
67. Howie MB, Michelsen LG, Porembka DT, et al. Anesthesia induction with remifentanil for patients undergoing CABG (Abstract). Anesth Analg 1996;82:S190
68. Royston D, Gupta S, Haigh A, et al. The pharmacokinetics of remifentanil injection during hypothermic cardiopulmonary bypass in humans (Abstract). Anesthesiology 1995;83:A384
69. Michelsen LG, Hoke JF, Hug CC Jr, et al. Pharmacokinetics of remifentanil in cardiac surgical patients (Abstract). Anesthesiology 1995;83:A379
70. Michelsen LG, Hug CC Jr, Woda RP, et al. Early extubation of CABG patients after remifentanil anesthesia (Abstract). Anesth Analg 1996;82:S314
71. Royston D. Remifentanil in cardiac surgery. Eur J Anaesth 1995;12:77-79
72. Howie MB, Kelly WB, Porembka DT, et al. Catecholamine response during CABG with remifentanil anaesthesia (Abstract). Anesth Analg 1996;82:S189
73. Bacon R, Chandrasekan V, Haigh A, et al. Early extubation after open-heart surgery with total intravenous anaesthetic technique. Lancet 1995;345:133-134
74. Duthie DJ, Stevens JJ, Doyle AR, Baddoo HH. Remifentanil and coronary artery surgery. Lancet 1995;345:649-650
75. Baker KZ, Ostapkovich N, Jackson T, et al. Cerebral blood flow reactivity is intact during remifentanil/N20 anesthesia (Abstract). Anesth Analg 1995;80:A27
76. Baker KZ, Ostapkovich N, Mack PF, et al. Cerebral blood flow reactivity is similar during remifentanil/N20 and fentanyl/N20 anesthesia (Abstract). Anesthesiology 1996;85:A180
77. Philip BK, Scuderi PE, Chung F, et al. Comparison of remifentanil/propofol to alfentanil/propofol for laparoscopic outpatient surgery (Abstract). Anesthesiology 1995; 83:A3
78. Chung F, Skinner EP, Jamerson BD, Reese PR. Recovery and reasons for discharge delay after remifentanil vs. alfentanil in outpatient surgery (Abstract). Anesth Analg 1996;82:S65
79. Camu F, Breivik H, Hagelberg A, et al. A double-blind, placebo controlled study of the safety and efficacy of remifentanil used as an adjunct sedative in patients receiving regional anaesthesia (Abstract). Anesthesiology 1995;83:A847
80. Desmonts JM, Aitkenhead AR, Camu F, et al. Comparison of remifentanil and propofol as adjunct therapy during regional anaesthesia (Abstract). Anesthesiology 1995;83:A857
81. Monk TG, Pulley DD, Jenkins WL, et al. Comparison of remifentanil and propofol as adjuncts to spinal anesthesia (Abstract). Anesth Analg 1996;82:S321
82. Mingus M, Rosenblatt M, Gainsburg D, et al. Comparison of remifentanil and propofol as adjuncts to peripheral regional anesthesia for ambulatory surgery (Abstract). Anesth Analg 1996;82:S319
83. Hughes SC, Kan RE, Rosen MA, et al. Remifentanil: ultra-short acting opioid for obstetric anesthesia (Abstract). Anesthesiology 1996;85:A894
84. Smith I. Monitored anesthesia care: how much sedation, how much analgesia? J Clin Anesth 1996;8:76S-80S
85. Smith I, Avramov M, White PF. Remifentanil versus propofol for monitored anesthesia care - effects on ventilation (Abstract). Anesthesiology 1995;83:A4
86. Smith I, Avramov M, White PF. Remifentanil versus propofol for monitored anesthesia care in the ambulatory setting (Abstract). Anesthesiology 1995;83:A5
87. Gold MI, Watkins WD, Sung YF, et al. Evaluation of remifentanil vs. remifentanil/ midazolam during monitored anesthesia care (MAC) (Abstract). Anesthesiology 1996; 85:A4
88. Reese PR, White PF, Lee JT, et al. Remifentanil vs. midazolam-remifentanil for monitored anesthesia care: anesthesiologist's assessment and patient satisfaction (Abstract). Anesth Analg 1996;82:S374
89. Avramov M, Smith I, White PF. Influence of sedation level on side effects and recovery after outpatient monitored anesthesia care (Abstract). Anesth Analg 1995;80:S23
90. Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth 1992;69:162-167
91. Ahmad S, Leavell M, Fragen RJ, et al. Use of remifentanil for analgesia during placement of ophthalmic nerve blocks (Abstract). Anesth Analg 1996;82:S3
92. Witkowski T, Azad SS, Lessin J, et al. Post-op analgesia with remifentanil: dosage and side effects (Abstract). Anesth Analg 1995;80:S554
93. Yarmush J, D'Angelo R, O'Leary C, et al. Remifentanil vs. morphine for acute postoperative analgesia (Abstract). Anesth Analg 1996;82:S504
94. Buerkle H, Yaksh TL. Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat. Anesthesiology 1996;84:94-102
95. Buerkle H, Yaksh TL. Continuous intrathecal administration of shortlasting mu opioids remifentanil and alfentanil in the rat. Anesthesiology 1996;84:926-935
96. Buerkle H, Yaksh TL. Spinal pharmacology after continuous administration of the new mu-opioid remifentanil in comparison to alfentanil in the animal model (Abstract). Anesthesiology 1995;83:A773